The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective (Q47819795)
Jump to navigation
Jump to search
scientific article published in July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective |
scientific article published in July 2003 |
Statements
1 reference
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective (English)
1 reference
Thorir D Bjornsson
1 reference
John T Callaghan
1 reference
Heidi J Einolf
1 reference
Volker Fischer
1 reference
Lawrence Gan
1 reference
Scott Grimm
1 reference
John Kao
1 reference
S Peter King
1 reference
Gerald Miwa
1 reference
Lan Ni
1 reference
Gondi Kumar
1 reference
James McLeod
1 reference
R Scott Obach
1 reference
Stanley Roberts
1 reference
Amy Roe
1 reference
Anita Shah
1 reference
Fred Snikeris
1 reference
John T Sullivan
1 reference
Donald Tweedie
1 reference
Jose M Vega
1 reference
John Walsh
1 reference
Steven A Wrighton
1 reference
Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group
1 reference
FDA Center for Drug Evaluation and Research (CDER)
1 reference
1 July 2003
1 reference
31
1 reference
7
1 reference
815-832
1 reference
Identifiers
1 reference
1 reference